1998 1999 2000 2001 2002 2003 2004
2005200620072008 2009 20102011
   In Press   

Select Publications by MPCI Faculty


Gurwitz JH. The age-gender interface in geriatric pharmacotherapy. J Women’s Health 2005;14:68-72.

• Aronson MP, Aronson PK, Howard AE, Morse AN, Young SB. Low risk of ureteral obstruction with “deep” uterosacral ligament fixation for transvaginal apical suspension. Am J Obstet Gynecol 2005;192:1530-6.

Morse AN, Hammer RA, CornellaJL, Loftus JC. Validation of a mouse adhesion reduction model using Seprafilm. J Gynecologic Surg 2005; 4:147-153.

• Hammer RA, Morse AN, Cornella JC, Keller RS, Hentz J, McDonald JA, Loftus JC Post-surgical adhesion reduction using intraperitoneal inoculation of hyaluronic acid- inducing adenoviral vector in murine model. J. Gynecologic Surg 2005; 5: 57-63.

• Gill SS, Rochon PA, Herrmann N, Lee PE, Sykora K, Gunraj N, Normand S, Gurwitz JH, Marras C, Wodchis WP, Mamdani M. Atypical antipsychotic drugs and risk of ischemic stroke: Population based retrospective cohort study. BMJ 2005;330-445.

• Doshi JA, Shaffer T, Briesacher B. National estimates of medication use in nursing homes: Findings from the 1997 Medicare Current Beneficiary Survey and the 1996 Medical Expenditure Survey. J Am Geriatric Soc 2005;53:438-443.

• Simon SR, Chan Ka, Soumerai SB, Wagner AK, Andrade SE, Feldstein AC, Lafata J, Davis RL, Gurwitz JH. Potentially inappropriate medication use among elderly persons in U.S. HMOs 2000-2001. J Am Geriatr Soc 2005;53:227-232.

Mazor KM, Simon SR, Yood RA, Martinson BC, Gunter MK, Reed GW, Gurwitz JH. Health plan members’ views on forgiving medical errors. Am J Manag Care 2005;11:49-52.

Gurwitz JH, Field TS, Judge J, Rochon P, Harrold LR, Cadoret C, Lee M, White K, LaPrino J, Erramuspe-Mainard J, DeFlorio M, Gavendo L, Auger J, Bates DW. The incidence of adverse drug events in two large academic long-term care facilities. Am J Med 2005;118:251-258.

• Sacks JJ, Harrold LR, Helmick CG, Gurwitz JH, Emani S, Yood RA. Validation of a surveillance case definition for arthritis. J Rheum 2005;32:340-347.

Andrade SE, Graham DJ, Staffa JA, Schech SD, Shatin D, La Grenade L, Goodman MJ, Platt R, Gurwitz JH, Chan KA. Health plan administrative databases can efficiently identify serious myopathy and rhabdomyolysis. J Clin Epi 2005;58:171- 174.

• Newton KM, Buist DS, Miglioretti DL, Beverly K, Hartsfield CL, Chan KA, Andrade SE, Wei F, Connelly MT, Kessler L. The impact of comorbidities on hormone use after the 2002 release of the Women’s Health Initiative. J Gen Intern Med 2005:20:350-356.

• Hartsfield CL, Connelly MT, Newton KM, Andrade SE, Wei F, Buist DS. Health system responses to the Women's Health Initiative findings on estrogen and progestin: organizational response. Journal of the National Cancer Institute 2005:113-115.

• Wei F, Miglioretti DL, Connelly MT, Andrade SE, Newton KM, Hartsfield CL, Chan KA, Buist DS. Changes in hormone use after the Women's Health Initiative estrogen and progestin trial by race, education, and income. Journal of the National Cancer Institute 2005:106-112

• McPhillips HA, Stille CJ, Smith D, Hecht J, Pearson J, Stull J, DeBellis K, Andrade S, Miller M, Kaushal R, Gurwitz J, Davis RL. Potential medication dosing errors in outpatient pediatrics. J Pediatrics 2005;147:761-767.

• Simon SR, Andrade SE, Ellis JL, Nelson WW, Gurwitz JH, Lafata JE, Davis RL, Feldstein A, Raebel MA. Baseline laboratory monitoring of cardiovascular medications among elderly health maintenance organization enrollees. J Am Geriatr Soc 2005;53:2165-2169.

• Raebel MA, Lyons EE, Andrade SE, Chan KA, Chester EA, Davis RL, Ellis JL, Feldstein A, Gunter MJ, Lafata JE, Long CL, Magid DJ, Selby JV, Simon SS, Platt R. Laboratory monitoring of high risk drugs at initiation of therapy in ambulatory care. J Gen Intern Med 2005;20:1120-1126.

• Godefroi R, Lkementowicz P, Pepler C, Lewis B, McDonough K, Goldberg RJ. Metabolic syndrome in a screened worksite sample: prevalence and predictors. Cardiology 2005;103:131-136.

• Godefroi R, Klementowicz P, Pepler C, Lewis B, McDonough K, Goldberg RJ. Levels of, and factors associated with, C-reactive protein in employees attending a company-sponsored cardiac screening program. Cardiology 2005;103:180-184.

• Trachtenberg F, Dugan E, Hall MA. How patients’ trust relates to their involvement in medical care. J Fam Pract 2005;54:344-52.

Dugan E, Trachtenberg F, Hall MA. Development of abbreviated measures to assess patient trust in a physician, a health insurer, and the medical profession. BMC Health Serv Res 2005;5:64.

• Rochon PA, Gurwitz JH, Sykora K, Mamdani M, Streiner DL, Garfinkel S, Normand SL, Anderson GM. Reader’s guide to critical appraisal of cohort studies: 1. Role and design. BMJ 2005;330:895-7.

• Graham DJ, Staffa JA, La Grenade L, Shatin D, Schech SD, Andrade SE, Gurwitz JH, Goodman MJ, Chan KA. Rhabdomyolysis and lipid-lowering drugs. JAMA 2005;293:1448-1449.

• Hankin C, Feldman S, Szczotka A, Stinger R, Fish L, Hankin D. A cost comparison of treatments of moderate to severe psoriasis. Drug Benefit Trends 2005;17:200-214.

• Hall MA, Trachtenberg F, Dugan E. The impact on patient trust of legalizing physician aid in dying. J Medical Ethics 2005;31:693-7.

• Wagner AK, Chan KA, Dashevsky I, Raebel MA, Andrade SE, Lafata JE, Davis RL, Gurwitz JH, Soumerai SB, Platt R. FDA drug prescribing warnings: Is the black box half empty or half full? Pharmacoepidemiol Drug Saf 2005;15:369-386.

• Allen Lapointe NM, Curtis LH, Chan KA, Kramer JM, Lafata JE, Gurwitz JH, Raebel MA, Platt R. Frequency of high-risk use of QT-prolonging medications. Pharmacoepidemiol Drug Saf 2005;15:361-368.

Briesacher B, Limcangco R, Simoni-Wastila L, Doshi J, Gurwitz JH. Evaluation of nationally-mandated drug use reviews to improve patient safety in nursing homes: a natural experiment. J Am Geriatric Soc 2005;53:991-996.

• Stuart B, Briesacher B, Shea DG, Cooper B, Baysac FS, Limcangco MR. Riding the rollercoaster: the ups and downs in out-of-pocket spending under the standard Medicare drug benefit, Health Affairs 2005; 24:1-10, Jul-Aug.

Briesacher B, Limcangco MR, Simoni-Wastila L, Doshi JA, Shea DG, Stuart B. The quality of antipsychotic prescribing in nursing homes. Arch Intern Med 2005;165:1280-1285.

Briesacher B, Stuart B, Doshi J, Wrobel MV. Medicare beneficiaries and the impact of gaining prescription drug coverage on inpatient and physician spending. Health Services Research 2005;40:1279-1296.

Briesacher BA, Orwig D, Seton M, Omar M, Kahler K. Medical care costs of Paget's disease of bone in a privately-insured population. Bone; 2005:37.

• Simoni-Wastila L, Zuckerman I, Singhal P, Hsu V, Briesacher BA. National estimates of exposure to prescription drugs with addiction potential in community- dwelling elders. Substance Abuse 2005;26:33-42.

Harrold LR, Andrade SE, Go AS, Buist AS, Eisner M, Vollmer WM, Chan KA, Frazier EA, Weller PF, Wechsler ME, Yood RA, Davis KJ, Platt R. Incidence of Churg-Strauss Syndrome (CSS) in asthma drug users: a population-based perspective. J Rheumatol 2005;32:1076-80.

• Raebel MA, Ellis JL, Andrade SE. Evaluation of gestational age and admission date assumptions used to determine prenatal drug exposure from administrative data. Pharmacoepidemiolo Drug Saf 2005;14:829-36.

• Roblin DW, Platt R, Goodman MJ, Hsu JT, Nelson WW, Smith DH, Andrade SE, Soumerai SB. Effect of increased cost-sharing on oral hypoglycemic use in five MCOs: How much is too much? Medical Care 2005;43:947-50.

Mazor KM, Andrade SE, Auger J, Fish L, Gurwitz JH. Communicating safety information to physicians: An examination of dear doctor letters. Pharmacoepidemiol Drug Saf 2005;14:869-75.

• Hornbrook MC, Hart G, Ellis JL, Bachman DJ, Ansell G, Greene SM, Wagner EH, Pardee R, Schmidt MM, Geiger A, Butani AL, Field T, et al. Building a virtual cancer research organization. J Natl Cancer Inst Monogr 2005;34:12-25.

Field TS, Gilman BH, Subramanian S, Fuller JC, Bates DW, Gurwitz JH. The costs associated with adverse drug events among older adults in the ambulatory setting. Med Care 2005;43:1171-6.

Field TS, Buist DSM, Doubeni C, Enger S, Fouayzi H, Hart G, Korner EJ, Lamerato L, Bachman DJ, Ellis J, Herrinton L, Hornbrook MC, Krajenta R, Liu L, Yao J. Disparities and survival among breast cancer patients. JNCI 2005;35:88-95.

Mazor KM, Ockene JK, Rogers JH, Carlin MM, Quirk ME. The relationship between checklist scores on a communication OSCE and patient satisfaction with communication. Advances in Health Sciences Education 2005;10:37-51.

• Wagner E, Greene S, Hart G, Field TS, Fletcher S, Geiger A, Herrinton L, Hornbrook M, Johnson C, Mouchawar J, Rolnick S, Stevens V, Taplin S, Tolsma D, Vogt T. Building a research consortium of large health systems: the Cancer Research Network. JNCI 2005;35:3-11.

• Rochon PA, Field TS, Bates DW, Lee M, Gavendo L, Erramuspe-Mainard J, Judge J, Gurwitz JH. Computerized physician order entry with clinical decision support in the long-term care setting: Insights from the Baycrest Centre for Geriatric Care. J Am Geriatr Soc 2005;53:1780-9.

Mazor KM, Fischer MA, Haley HL, Hatem D, Roger JH, Quirk ME. Factors influencing preceptors’ responses to medical errors: a factorial survey. Academic Med 2005;80:S88-92.

Mazor KM, Fischer MA, Haley HL, Hatem D, Quirk ME. Teaching and medical errors: primary care preceptors’ views. Medical Educ 2005;39:982-990.

• Billings-Gagliardi S, Mazor KM. Development and validation of the Stroke Action Test (STAT) Stroke 2005;36:1035-9.

• Quirk ME, Mazor KM, Haley HL, Wellman S, Keller D, Hatem K, Keller LA. Who should score an OSTE? Validity and reliability of ratings in an objective structured teaching exam (OSTE). Teaching and Learning in Med 2005;17:202-209.

• Schwartz CE, Clive DM, Mazor KM, Ma Y, Reed G, Clay M. Detecting attitudinal changes about death and dying as a result of end-of-life care curriculum for medical undergraduates. J Paliative Med 2005;8:975-86.

Walsh KE, Kaushal R, Chessare J. How to avoid pediatric medication errors: a user’s guide to the literature. Arch Disease in Childhood 2005;90:698-702.

• Rochon PA, Stukel TA, Sykora K, Gill SS, Garfinkel S, Marras C, Gurwitz JH, et al. Atypical antipsychotics and parkinsonism. Arch Intern Med 2005;165:1882-8.

• Lash TL, Gurwitz JH, Silliman RA. Physicians’ assessments of adjuvant tamoxifen’s effectiveness in older patients with primary breast cancer. J Am Geriatric Soc 2005;53:1889-96.

• Chan KA, Davis RL, Gunter ML, Gurwitz JH, Herrinton LJ, Nelson WW, Raebel MA, Roblin DW, Smith DH, Platt R. The HMO Research Network Center for Education and Research in Therapeutics. Pharmacoepidemiology, 4th Edition. Strom B. John Wiley & Sons, LTD, West Sussex, England 2005

• Antonelli RC, Stille CJ, Freeman L. Enhancing collaboration between primary and subspecialty care providers for children and youth with special health care needs. Washington, DC: Georgetown University Center for Child and Human Development, 2005.

• McPhillips H, Stille C, Smith D, et al. Methodological challenges in describing medication dosing errors in children. In: Henriksen K, Battles JB, Marks E, Lewin DI, eds. Advances in Patient Safety: From Research to Implementation. Vol. 2: Concepts and Methodology. Rockville, MD: Agency for Healthcare Research and Quality, 2005, pp.213-223.

Gurwitz JH. Commentary for Medication Misunderstanding, AHRQ Web M&M, 2005 http.//webmm.ahrq.gov (Http://webmm.ahrq.gov/printview.aspz? Case ID=104).

Mailing Address
Meyers Primary Care Institute
630 Plantation Street
Worcester, MA 01605

425 North Lake Ave
Worcester, MA 01605
Tel: 508-791-7392
Fax: 508-595-2200